Zurich Insurance Group’s United Therapeutics UTHR Stock Holding History

Zurich Insurance Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.9M	Buy	69,927 +35,099	+101%	+$19.8M	0.26%	105
2026 Q1	$20.7M	Sell	34,828 -14,670	-30%	-$7.31M	0.16%	157
2025 Q4	$24.1M	Buy	+49,498	New	+$23.1M	0.17%	140
2015 Q4	–	Sell	-61,899	Closed	-$8.12M	–	335
2015 Q3	$8.12M	Buy	+61,899	New	+$9.93M	0.3%	112

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Zurich Insurance Group's UTHR Position: Q2 2026 in Review

Zurich Insurance Group increased its United Therapeutics (UTHR) stake by 101% in Q2 2026, buying an estimated $19.8M and bringing the position to 69,927 shares worth $37.9M. The position accounts for 0.26% of the portfolio, ranked #105.

Zurich Insurance Group first reported a position in UTHR in Q3 2015 and has held it in 4 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Zurich Insurance Group held 69,927 shares of United Therapeutics worth $37.9M as of Q2 2026.
Zurich Insurance Group bought 35,099 United Therapeutics shares in Q2 2026, an estimated $19.8M.
United Therapeutics made up 0.26% of Zurich Insurance Group's portfolio in Q2 2026, its #105 holding.
Zurich Insurance Group first reported a position in United Therapeutics in Q3 2015 and has held it in 4 quarters since.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.